GeminIQ Website Logo

Viewing ACATD free

Start free trial

Subscribe for full history, 50+ metrics, screener, watchlist...

NP Life Sciences Health Industry Group Inc.

ACATD

Companies in Services-Educational Services

LAURGHCLOPECVSALRNPRDO

NP Life Sciences Health Industry Group Inc. (ACATD) — SEC Financial Statements & Analysis

NP Life Sciences Health Industry Group Inc. (ACATD) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
0000000000000
Assets Current
Assets Noncurrent
Prepaid Expense Current
000000000--0-
Assets
0000000000000
Liabilities And Stockhold…
Contract With Customer Liability Current
-0000--0-----
Accounts Payable Current
0000000------
Liabilities Current
Liabilities Current
0---0--------
Other Notes Payable Current
000-0--------
Taxes Payable Current
-00----------
Accrued Liabilities Current
0000000000000
Liabilities Noncurrent
Liabilities Noncurrent
0------------
Liabilities
0000000000000
Common Stock Value
0000000000000
Stockholders Equity
Additional Paid In Capital
0000000000000
Stockholders Equity
0000000000000
Retained Earnings Accumulated Deficit
-0-0-0-0-0-0-0-0-0-0-0-0-0
Liabilities And Stockholders Equity
0000000000000
Preferred Stock Par Or Stated Value Per Share
0000000000000
Preferred Stock Shares Authorized
30303030303030303030303030
Preferred Stock Shares Issued
0000000000000
Preferred Stock Shares Outstanding
0000000000000
Common Stock Par Or Stated Value Per Share
0000000000000
Common Stock Shares Authorized
320320320320320320320320320320320320320
Common Stock Shares Issued
43434343434343434343434343
Shares Outstanding
43434343434343434343434343

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20230.00%7.84%3.05%-2.96%-2.96%-2.96%6.80%6.80%9.71%-29.81%-29.81%-53.85%
20220.00%0.00%-7.14%130.77%130.77%-7.69%260.00%260.00%260.00%0.00%0.00%7.84%
20210.00%0.00%0.00%0.00%0.00%0.00%47.06%47.06%47.06%---

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Leverage & Debt
Debt to Equity
3.69
-
-
-
5.62
-
-
-
-
-
-
-
-
Interest Coverage TTM
-230.00
17,257.33
27,925.67
4,487.33
-
-
-
-
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
-0.00
0.00
0.00
-
-0.00
-0.00
-0.00
-
-
-
-
-
-
Free Cash Flow Per Share TTM
-0.00
0.00
0.00
0.00
0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-0.42%
25.80%
37.38%
10.20%
-18.48%
-5.92%
-124.86%
-
-
-
-
-
-873.94%
Net Profit Margin TTM
-1.78%
25.59%
37.29%
10.20%
-18.49%
-5.91%
-124.85%
-
-
-
-
-
-873.77%
Growth Metrics
Net Revenue Growth (1Y)
61.39%
258.39%
1,395.92%
-
-
-
-
-
-100.00%
-100.00%
-100.00%
-
-
Net Income Growth (1Y)
-84.43%
-1,650.74%
-546.81%
-118.56%
-71.29%
-97.23%
-84.95%
-42.07%
-49.89%
-35.89%
-35.48%
-
-
EPS Growth (1Y)
-84.43%
-1,650.74%
-546.81%
-118.56%
-71.29%
-97.23%
-84.95%
-42.07%
-49.89%
-35.89%
-35.48%
-
-
Calculated Values
Free Cash Flow TTM
-73.61K
55.24K
102.17K
116.96K
93.87K
-18.06K
-40.15K
-66.31K
-90.63K
-119.98K
-127.79K
-132.80K
-124.32K
Net Debt
-70.61K
-84.55K
-125.11K
-140.08K
-121.86K
-6.95K
-575.00
-23.12K
-27.99K
-25.01K
-40.73K
-89.43K
-118.61K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial
No insider data available.

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

Research Faster.
Invest Smarter.

Start 7-day free trial

NP Life Sciences Health Industry Group Inc. (ACATD) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.